Tuberculosis (TB)

TB/HIV Research Priorities in Resource-Limited Settings
Expert Consultation, WHO, Geneva, 14-15 February 2005

Objectives, Expected Outcome and Process

Objectives of the consultation

  • To define TB/HIV research priorities and outline research relevance, methodology and feasibility in the context of programme activities.
  • To solicit and promote TB/HIV research priorities capacity building at country level through the involvement of national and international agencies

Expected outcomes

  • TB/HIV research priorities defined
  • Plan to follow up the implementation of TB/HIV research priorities defined


The technical consultation will be a consultation for exchange of evidence from selected populations, experiences, views and opinions among individual participants and partner organizations. The main aim of the meeting is to develop TB/HIV research priorities. Should discrepancies emerge between current policy and new evidence, ad-hoc groups will be formed to then inform WHO on the need to revise current policy.

Papers to summarise the latest available evidence on ART/TB (including a database on ongoing/funded studies on drug-to-drug interaction, immune reconstitution/clinical management), co-trimoxazole prophylaxis, preventive treatment of latent TB, smear-negative TB and, intensified case finding will be made available to the participants before the meeting. Experts on economic evaluation, substance use, adherence, human resources and TB in children will be invited to contribute to the development of the TB/HIV research priorities. Plenary presentations will be used to highlight major issues relevant to implement and evaluate the TB/HIV package. The plenary presentations will be followed by Discussion Groups. These will be led by a facilitator, and each discussion group will designate a rapporteur. The products of the discussion groups will be presented in plenary and discussion will be centred on how the proposed operational research priorities will be mainstreamed within the implementation of collaborative TB/HIV activities at country level.